東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Mucosal delivery of drugs and biolog...

Muttil, Pavan.

FindBook

Google Book

Amazon

博客來

Mucosal delivery of drugs and biologics in nanoparticles

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Mucosal delivery of drugs and biologics in nanoparticles/ edited by Pavan Muttil, Nitesh K. Kunda.
其他作者:	Muttil, Pavan.
出版者:	Cham :Springer International Publishing : : 2020.,
面頁冊數:	viii, 277 p. :ill., digital ;24 cm.
內容註:	Section I Background -- Introduction to Nanomedicine -- Characterization of Nanoparticles -- Section II Drugs and Biologics Encapsulated in Nanoparticles -- Routes of Delivery -- Small molecule Delivery -- Peptide and Protein Delivery -- Gene Delivery (siRNA/CRISPR) -- Phage Therapy -- Section III Diseases -- Non-infectious Diseases -- Infectious Diseases -- Cancer -- Section IV Host Interactions with Nanoparticles -- Interaction of Nanoparticles with Epithelial and Immune Cells -- Toxicity of Nanoparticles to the Host -- Nanoparticle Pharmacokinetics and Pharmacodynamics -- Section V MIscellanous -- Nanoparticles as Theranostics -- Regulatory Perspectives -- Manufacturing Scale-up of Nanoparticles.
Contained By:	Springer eBooks
標題:	Drug delivery devices. -
電子資源:	https://doi.org/10.1007/978-3-030-35910-2
ISBN:	9783030359102

Mucosal delivery of drugs and biologics in nanoparticles
Mucosal delivery of drugs and biologics in nanoparticles[electronic resource] /edited by Pavan Muttil, Nitesh K. Kunda. - Cham :Springer International Publishing :2020. - viii, 277 p. :ill., digital ;24 cm. - AAPS advances in the pharmaceutical sciences series,v.412210-7371 ;. - AAPS advances in the pharmaceutical sciences series ;v.41..

Section I Background -- Introduction to Nanomedicine -- Characterization of Nanoparticles -- Section II Drugs and Biologics Encapsulated in Nanoparticles -- Routes of Delivery -- Small molecule Delivery -- Peptide and Protein Delivery -- Gene Delivery (siRNA/CRISPR) -- Phage Therapy -- Section III Diseases -- Non-infectious Diseases -- Infectious Diseases -- Cancer -- Section IV Host Interactions with Nanoparticles -- Interaction of Nanoparticles with Epithelial and Immune Cells -- Toxicity of Nanoparticles to the Host -- Nanoparticle Pharmacokinetics and Pharmacodynamics -- Section V MIscellanous -- Nanoparticles as Theranostics -- Regulatory Perspectives -- Manufacturing Scale-up of Nanoparticles.

This book focuses on the application of nanotechnology to deliver drugs and biological agents by the mucosal routes of administration i.e. nasal, pulmonary, buccal, and oral routes.It provides an overview of nanotechnology in drug delivery with a description of different types of nanoparticles, methods of preparation and characterization, and functionalization for site-specific drug delivery. Mucosal Delivery of Drugs and Biologics in Nanoparticles emphasize the use of nanoparticles in treating various cancers and infectious diseases. It broadens the use of nanoparticles by including biologics, including vaccines and immunotherapies, apart from drugs. It acknowledges the concerns around the potential toxicity of nanoparticles to the host; few chapters will discuss the biodistribution of these nanoparticles when mucosal routes of administration are employed. Further, the interaction of nanoparticles with the host's immune cells is discussed. Moreover,it reviews the regulatory aspects of nanotechnology in product development, especially when delivered by the mucosal route of administration. Lastly, discusses the challenges and opportunities to manufacture nanoparticles on an industrial scale. This book will be the first of its kind to focus on the design, development and delivery of nanoparticles when administered by different mucosal routes.

ISBN: 9783030359102

Standard No.: 10.1007/978-3-030-35910-2doiSubjects--Topical Terms:

2120623
Drug delivery devices.

LC Class. No.: RS210 / .M836 2020

Dewey Class. No.: 615.19

Mucosal delivery of drugs and biologics in nanoparticles
LDR:03154nmm a2200337 a 4500 001 2216741
003 DE-He213
005 20200727141009.0
006 m d
007 cr nn 008maaau
008 201120s2020 sz s 0 eng d
020 $a 9783030359102 $q (electronic bk.)
020 $a 9783030359096 $q (paper)
024 7 $a 10.1007/978-3-030-35910-2 $2 doi
035 $a 978-3-030-35910-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RS210 $b .M836 2020
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a TDC $2 thema
082 0 4 $a 615.19 $2 23
090 $a RS210 $b .M942 2020
245 0 0 $a Mucosal delivery of drugs and biologics in nanoparticles $h [electronic resource] / $c edited by Pavan Muttil, Nitesh K. Kunda.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a viii, 277 p. : $b ill., digital ; $c 24 cm.
490 1 $a AAPS advances in the pharmaceutical sciences series, $x 2210-7371 ; $v v.41
505 0 $a Section I Background -- Introduction to Nanomedicine -- Characterization of Nanoparticles -- Section II Drugs and Biologics Encapsulated in Nanoparticles -- Routes of Delivery -- Small molecule Delivery -- Peptide and Protein Delivery -- Gene Delivery (siRNA/CRISPR) -- Phage Therapy -- Section III Diseases -- Non-infectious Diseases -- Infectious Diseases -- Cancer -- Section IV Host Interactions with Nanoparticles -- Interaction of Nanoparticles with Epithelial and Immune Cells -- Toxicity of Nanoparticles to the Host -- Nanoparticle Pharmacokinetics and Pharmacodynamics -- Section V MIscellanous -- Nanoparticles as Theranostics -- Regulatory Perspectives -- Manufacturing Scale-up of Nanoparticles.
520 $a This book focuses on the application of nanotechnology to deliver drugs and biological agents by the mucosal routes of administration i.e. nasal, pulmonary, buccal, and oral routes.It provides an overview of nanotechnology in drug delivery with a description of different types of nanoparticles, methods of preparation and characterization, and functionalization for site-specific drug delivery. Mucosal Delivery of Drugs and Biologics in Nanoparticles emphasize the use of nanoparticles in treating various cancers and infectious diseases. It broadens the use of nanoparticles by including biologics, including vaccines and immunotherapies, apart from drugs. It acknowledges the concerns around the potential toxicity of nanoparticles to the host; few chapters will discuss the biodistribution of these nanoparticles when mucosal routes of administration are employed. Further, the interaction of nanoparticles with the host's immune cells is discussed. Moreover,it reviews the regulatory aspects of nanotechnology in product development, especially when delivered by the mucosal route of administration. Lastly, discusses the challenges and opportunities to manufacture nanoparticles on an industrial scale. This book will be the first of its kind to focus on the design, development and delivery of nanoparticles when administered by different mucosal routes.
650 0 $a Drug delivery devices. $3 2120623
650 0 $a Inhalers. $3 2056443
650 0 $a Nanoparticles. $3 605747
650 1 4 $a Pharmaceutical Sciences/Technology. $3 1001579
700 1 $a Muttil, Pavan. $3 3449396
700 1 $a Kunda, Nitesh K. $3 3449397
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a AAPS advances in the pharmaceutical sciences series ; $v v.41. $3 3449398
856 4 0 $u https://doi.org/10.1007/978-3-030-35910-2
950 $a Biomedical and Life Sciences (Springer-11642)